Drug Shortage Report for CERVARIX

Last updated on 2018-11-15
Report ID 45668
Drug Identification Number 02342227
Brand name CERVARIX
Common or Proper name Human Papillomavirus vaccine Types 16 and 18
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Strength(s) 20MCG 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BM
ATC description VIRAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-04-09
Estimated end date 2018-11-15
Actual end date 2018-11-14
Shortage status Resolved
Updated date 2018-11-14
Company comments
Health Canada comments
Company contact information 1-800-387-7374